Pioglitazone: all 341 studies that test it
Page 2 of 4. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)CompletedNCT00736996Phase 2Results posted
- Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.CompletedNCT00727857Phase 3Results posted
- MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)CompletedNCT00722371Phase 3Results posted
- Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.CompletedNCT00708175Phase 4Results posted
- Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic SyndromeCompletedNCT00671515Phase 2Results posted
- Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin ResistanceCompletedNCT00665353Phase 2Results posted
- Myocardial Function & FFA Metabolism in HIV Metabolic SyndromeCompletedNCT00656851Not applicableResults posted
- Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.CompletedNCT00655863Phase 3Results posted
- Efficacy vs Placebo as Initial Combination Therapy With PioglitazoneCompletedNCT00641043Phase 3Results posted
- Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese AsthmaticsCompletedNCT00634036Phase 2Results posted
- Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal FunctionTerminatedNCT00586261Not applicableResults posted
- Mechanisms Underlying Metabolic Syndrome in ObesityCompletedNCT00579813Phase 4Results posted
- Randomized, Double-blind, Active-controlled, Study of Rivoglitazone in Type 2 Diabetes MellitusTerminatedNCT00571519Phase 3Results posted
- PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular DiseaseCompletedNCT00554853Phase 3Results posted
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.CompletedNCT00545233Phase 4Results posted
- Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy VolunteersCompletedNCT00531882Not applicableResults posted
- Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)CompletedNCT00511108Phase 1Results posted
- Effects of PPAR Ligands on Ectopic Fat Accumulation and InflammationCompletedNCT00470262Not applicableResults posted
- Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin ResistanceCompletedNCT00443755Phase 2Results posted
- Pioglitazone to Treat Fatty Liver in People With HIV InfectionCompletedNCT00441272Phase 2Results posted
- Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate CancerCompletedNCT00427999Phase 2Results posted
- Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCompletedNCT00395512Phase 3Results posted
- Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00328627Phase 3Results posted
- Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis (CF) Lung DiseaseCompletedNCT00322868Not applicableResults posted
- Optimizing Body Composition for Function in Older AdultsCompletedNCT00315146Phase 4Results posted
- Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDLCompletedNCT00300365Phase 2Results posted
- Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCompletedNCT00286494Phase 3Results posted
- Preservation of Beta-cell Function in Type 2 Diabetes MellitusCompletedNCT00232583Not applicableResults posted
- Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With SchizophreniaCompletedNCT00231894Phase 4Results posted
- Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes MellitusCompletedNCT00225277Phase 3Results posted
- Actos Now for Prevention of Diabetes (ACT NOW)CompletedNCT00220961Phase 3Results posted
- Polycystic Ovary Syndrome (PCOS) and Sleep ApneaTerminatedNCT00203996Phase 4Results posted
- The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in HumansCompletedNCT00179400Phase 4Results posted
- ARREST PAD (Peripheral Arterial Disease)CompletedNCT00153166Phase 2/3Results posted
- Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaCompletedNCT00099021Phase 2Results posted
- Insulin Resistance Intervention After Stroke TrialCompletedNCT00091949Phase 3Results posted
- Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)CompletedNCT00063622Phase 3Results posted
- Treating Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00062764Phase 2Results posted
- Enhancing PCOS Management for Better Outcomes of Intracytoplasmic Sperm InjectionActive, not recruitingNCT07604779Not applicable
- Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOSCompletedNCT07472179Not applicable
- A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy ParticipantsCompletedNCT07444424Phase 1
- The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic RatsCompletedNCT07083232Phase 4
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.CompletedNCT06851962Phase 4
- The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and CachexiaActive, not recruitingNCT05919147Phase 2
- Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 DiabetesStatus unknownNCT05629806Phase 3
- Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisStatus unknownNCT05605158Phase 3
- Comparison of the Effects of Metformin and Pioglitazone on Liver Enzymes and Ultrasound Changes in Non-Diabetic Non-Alcoholic Fatty LiverCompletedNCT05521633Phase 3
- Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.Status unknownNCT05519813Phase 4
- Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 DiabetesStatus unknownNCT05473806Phase 4
- A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.CompletedNCT05411965Phase 1
- Pioglitazone and Insulin Resistance in ADTWithdrawnNCT05098327Phase 3
- Insulin Resistance and Androgen Deprivation TherapyWithdrawnNCT04995978Phase 2
- Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty LiverStatus unknownNCT04976283Phase 4
- A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinCompletedNCT04885712Phase 3
- Value of Using Pioglitazone in Chronic Myeloid Leukemia TreatmentCompletedNCT04883125Phase 2
- Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse PreventionCompletedNCT04843046Phase 2
- Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.CompletedNCT04794127Phase 2
- Drug Interaction Study of MGL-3196 With PioglitazoneCompletedNCT04671056Phase 1
- Insulin Resistance Following ADT for Prostate CAWithdrawnNCT04658849Early Phase 1
- Targeting Beta-cell Failure in Lean Patients With Type 2 DiabetesCompletedNCT04657939Phase 4
- Effect of Pioglitazone on T2DM Patients With COVID-19Status unknownNCT04604223Phase 4
- Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19CompletedNCT04535700Phase 4
- GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot StudyCompletedNCT04473274Phase 4
- Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic AgentsStatus unknownNCT04287387Phase 4
- Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary SyndromeCompletedNCT04113889Phase 2
- Dapagliflozin Plus Pioglitazone in T1DMActive, not recruitingNCT03878459Phase 4
- Effect of Pioglitazone Administered to Patients With AdrenomyeloneuropathyCompletedNCT03864523Phase 2
- Antidiabetic Drugs for Steatotic Liver DiseaseCompletedNCT03646292Phase 4
- Pioglitazone Versus Metformin as First Treatment in Infertile Women With Polycystic Ovary SyndromeCompletedNCT03566225Early Phase 1
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyCompletedNCT03499704Phase 4
- Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450sCompletedNCT03457597Phase 1
- Insulin Signaling in Skeletal MuscleWithdrawnNCT03452267Phase 2/3
- Study of Pioglitazone in Sporadic Inclusion Body MyositisCompletedNCT03440034Phase 1
- CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)CompletedNCT03335956Phase 1
- Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar ProteinosisCompletedNCT03231033Phase 1
- Impacts of PIO/MET Following Short-term Intensive Insulin Treatment in Newly Diagnosed Type 2 DiabetesStatus unknownNCT03196362Phase 4
- Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus SulfonylureaCompletedNCT03125694Phase 3
- Pioglitazone Therapy for Chronic Granulomatous DiseaseTerminatedNCT03080480Phase 1/2
- A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)TerminatedNCT03060772Phase 2
- Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AMLTerminatedNCT02942758Phase 2
- Brown Fat Activation StudyCompletedNCT02919176Early Phase 1
- Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DMStatus unknownNCT02887625Not applicable
- HbA1c Variability in Type II DiabetesActive, not recruitingNCT02879409Not applicable
- Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular ResponseCompletedNCT02852486Phase 2
- A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLCStatus unknownNCT02852083Phase 2
- Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW)Active, not recruitingNCT02767063Phase 1/2
- An Extension Study of PEAK TrialTerminatedNCT02763007Phase 4
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mgCompletedNCT02753803Phase 1
- Response of Individuals With Ataxia-Telangiectasia to Metformin and PioglitazoneCompletedNCT02733679Phase 4
- Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOSCompletedNCT02689843Early Phase 1
- Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous LeukemiaStatus unknownNCT02687425Phase 2
- TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.CompletedNCT02653209Phase 4
- Skin Blood Flow Response to Insulin Iontophoresis in Pressure Ulcers of SCIWithdrawnNCT02585765Phase 2
- Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)CompletedNCT02535832Phase 1
- A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover MarkersStatus unknownNCT02429232Phase 4
- Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus AlogliptinStatus unknownNCT02426294Phase 4
- Drug-drug Interaction Study of GSK1278863 With Pioglitazone, Rosuvastatin and Trimethoprim in Healthy Adult VolunteersCompletedNCT02371603Phase 1
- Pharmacokinetic and Safety Study of Cenicriviroc and Pioglitazone, When Dosed Alone or in CombinationCompletedNCT02342067Phase 1
- Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes ManagementStatus unknownNCT02315287Phase 4
- Effect of Obesity-derived Cytokines on Protein Turnover and Carbohydrate Metabolism in Human Skeletal MuscleCompletedNCT02305069Not applicable